Missouri orders Eli Lilly to drop 340B claims-data condition after hospital cut-off

By ··1 min read·4 sources

Missouri Attorney General Catherine Hanaway sent Eli Lilly a cease-and-desist letter alleging its requirement that 340B hospitals hand over claims data violates state consumer protection law. Lilly had cut University of Missouri Health Care off from 340B pricing in July.

Missouri Attorney General Catherine Hanaway sent a cease-and-desist letter to Eli Lilly and Company on October 26, 2026, directing it to stop conditioning 340B Drug Pricing Program discounts for Missouri hospitals on the submission of claims data. The letter gives Lilly until November 26 to end the requirement and orders it to stop using claims data already collected under the policy.

Lilly's policy, effective from February 2026, requires 340B covered entities to submit claims data for every dispensation of any Lilly product, regardless of setting, including in-house pharmacy and medical claims. According to the letter, Lilly cut University of Missouri Health Care, which operates seven hospitals, off from 340B pricing on its products from July 2 after the system declined to provide the data. The health system later agreed to supply it temporarily while reserving its legal rights.

The attorney general alleges the policy violates the Missouri Merchandising Practices Act by promising federally required discounts while withholding them from facilities that refuse to share additional data. Eleven states have laws barring manufacturers from conditioning 340B discounts on claims data. Missouri is not one of them, which is why the state relies on its consumer protection statute.

Lilly has said the data is needed to identify duplicate discounts, including overlap with Inflation Reduction Act negotiated prices, and to prevent fraud, waste and abuse in the program. No direct response to the Missouri letter was reported.

A cease-and-desist letter is a formal demand, not a court ruling, and no judge has found the policy unlawful. The action adds a state enforcement front to a dispute the American Hospital Association has pressed with HRSA and with Lilly directly since January.

Sources

  1. drugtopics.com · drugtopics.com/view/missouri-challenges-lilly-s-340b-data-policy-what-stakeholders-should-…
  2. statnews.com · statnews.com/pharmalot/2026/10/27/missouri-ag-warns-lilly-340b-drug-pricing-data/
  3. beckershospitalreview.com · beckershospitalreview.com/pharmacy/missouri-attorney-general-orders-eli-lilly-to-end-340b-…
  4. aha.org · aha.org/2026-01-26-aha-urges-hrsa-stop-eli-lillys-new-policy-340b-hospitals-going-effect

Cite this report

The Precedent. "Missouri orders Eli Lilly to drop 340B claims-data condition after hospital cut-off." October 28, 2026. https://theprecedent.org/article/missouri-orders-eli-lilly-to-drop-340b-claims-data-condition-after-hospital-cut

Companies in this report